Comprehensive Police Fatigue Management Program

The recruitment status of this study is unknown because the information has not been verified recently.
Verified May 2010 by Brigham and Women’s Hospital.   Recruitment status was  Active, not recruiting

First Received on September 13, 2005.  
Last Updated on May 3, 2010  
History of Changes
This Clinical Trial Sponsored By: Brigham and Women’s Hospital
Information provided by: Brigham and Women’s Hospital
ClinicalTrials.gov Identifier: NCT00246051
 

Purpose for Clinical Trial

Police officers work some of the most demanding schedules known, which increases their risk of sleep deprivation and sleep disorders. The need to work frequent overnight shifts and long work weeks leads to acute and chronic partial sleep deprivation as well as misalignment of circadian phase. The public expects officers to perform flawlessly, but sleep deprivation and unrecognized sleep disorders significantly degrade cognition, alertness, reaction time and performance. In addition, both acute and chronic sleep deprivation adversely affect personal health, increasing the risk of gastrointestinal and heart disease, impairing glucose metabolism, and substantially increasing the risk of injury due to motor vehicle crashes.

We propose to conduct a randomized, prospective study of the effect on the safety, health, and performance of a police department of a Comprehensive Police Fatigue Management Program (CPFMP) consisting of the following interventions:

  1. scheduling improvements and policy developments to mitigate the adverse effects of extended duration work shifts and long work weeks;
  2. identification and treatment of police with sleep disorders;
  3. caffeine re-education; and
  4. initiation of a sleep, health and safety educational program.

These interventions were chosen because we believe them most likely to lead to measurable improvements on work hours, health, safety, and job performance, and because they are cost effective. The success of the CPFMP will be assessed through an experimental comparison with a standard treatment group that will receive sleep education in the absence of any accompanying interventions. The overall goal of our team will be to develop and test the implementation of policy and scheduling improvements and a sleep health detection and treatment program that can be disseminated to practitioners, policymakers and researchers nationwide to reduce police officer fatigue and stress; enhance the ability of officers and their families to cope with shift schedules; improve the health, safety and performance of law enforcement officers; and thereby improve public safety.

Condition Study Intervention
Sleep Disorders
Sleep Apnea, Obstructive
Restless Legs Syndrome
Sleep Disorders, Circadian Rhythm
Sleep Initiation and Maintenance Disorders
Behavioral: Sleep Hygiene Education
Procedure: Sleep Disorders Screening and Treatment

Study Type: Study Interventional
Study Design: Allocation: Randomized
Endpoint Classification: Safety/Efficacy Study
Study Intervention Model: Factorial Assignment
Masking: Open Label
Primary Purpose: Diagnostic
Official Title: Testing the Effectiveness of a Comprehensive Fatigue Management for the Police

Resource links provided by NLM:

MedlinePlus related topics:
Fatigue
Restless Legs
Sleep Apnea
Sleep Disorders

U.S. FDA Resources

Further study details as provided by Brigham and Women’s Hospital:

Primary Outcome Measures For Clinical Trial:

  • Motor vehicle accidents as a function of miles traveled
  • Number of on-the-job injuries
  • Number of citations issued
  • Number of arrests made
  • Number of warnings issued
  • Number of officer-initiated vehicle assists
  • Number of sick leave days
  • Sleep duration
  • Sleep quality
  • Alertness
  • Performance

Secondary Outcome Measures For Clinical Trial:

  • Job satisfaction
  • Burnout
  • Works hours

Estimated Enrollment: 3600
Study Start Date: November 2005
Estimated Study Completion Date: December 2010
Estimated Primary Completion Date: December 2009 (Final data collection date for primary outcome measure)
Study Intervention Details:

    Behavioral: Sleep Hygiene Education

    An education program, consisting of materials from experts in the field of fatigue management, will be provided to all police officers in the intervention group and their families. Videotapes, slides, handouts and other educational material will be compiled to create a variety of information sources for police officers and families. Examples of materials to be incorporated into this training program would be the ‘Health and Safety’ pamphlet (Circadian Technologies), the ‘Shiftwork Training Video’ and the training CD-ROM entitled ‘Awake at the Wheel’ (Alertness Solutions), and a take-home booklet entitled ‘Living Well with Shiftwork’ (Dr. Richard Coleman).

    Procedure: Sleep Disorders Screening and Treatment

    If they don’t meet the criteria they will be disempanelled. If + on the Berlin they will be given an appt. If they meet OSA criteria they will use an OSA device & will be asked to see the techs. Then given a 2nd clinic in 1-2 weeks.

    Officers will see a Dr who will review the report. If they meet 1 or more of the criteria they will be referred for CPAP. If need treatment they will be prescribed (CPAP) therapy. Officers given a 3rd clinic visit in 2-3 weeks.

    Staff will collect weight, bp & pulse. Data from the device will be downloaded & reviewed by the techs. If needed, a 4th follow-up visit may be scheduled. A nurse at SHC will be available for help for the rest of the study. The nurse, will evaluate whether further follow-up is needed. Officers who continue to have problems will be monitored for up to 3 months.

    They will be contacted by SHC at approx 3, 6 & 12 months. After 12 months, the study will be ended & the patient referred to their PCP.

  Eligibility

Ages Eligible for Study:   18 Years and older
Genders Eligible for Study:   Both
Accepts Healthy Volunteers:   Yes
Criteria

Inclusion Criteria:

  • Active Sworn Police Officers

Exclusion Criteria:

  Contacts and Locations

Please refer to this study by its ClinicalTrials.gov identifier: NCT00246051

Locations
United States, Massachusetts
Brigham and Women’s Hospital
Boston, Massachusetts, United States, 02115
Sponsors and Collaborators
Brigham and Women’s Hospital
Investigators
Principal Investigator: Charles A. Czeisler, Ph.D., M.D. Brigham and Women’s Hospital
  More Information

No publications provided

Responsible Party: Charles A. Czeisler, Ph.D., M.D., Brigham and Women’s Hospital
ClinicalTrials.gov Identifier: NCT00246051    
History of Changes
Other Study ID Numbers:

Leave a Reply

You can use these HTML tags

<a href="" title=""> <abbr title=""> <acronym title=""> <b> <blockquote cite=""> <cite> <code> <del datetime=""> <em> <i> <q cite=""> <s> <strike> <strong>

  

  

  

11 + seven =